Simultaneous dual-isotope SPECT/CT with (99m)Tc- and (111)In-labelled albumin microspheres in treatment planning for SIRT

M. Palmowski, A. Goedicke, A. Vogg, G. Christ, G. Muhlenbruch, H.J. Kaiser, R.W. Gunther, C.K. Kuhl, F.M. Mottaghy, F.F. Behrendt

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Scopus)

Abstract

OBJECTIVES: To investigate simultaneous dual-isotope SPECT/CT with two differently radioisotope-labelled albumin-microsphere fractions for treatment planning of hepatic radioembolisation. METHODS: In addition to (99m)Technetium-labelled albumin microspheres (commercially available), we performed labelling with (111)Indium. Binding stability of (111)Indium-labelled microspheres was tested in vitro and in vivo in mice. Simultaneous dual-isotope SPECT/CT imaging was validated in an anthropomorphic torso phantom; subsequently, dual-isotope SPECT/CT was performed under in-vivo conditions in pigs (n = 3) that underwent transarterial injection of (99m)Technetium- and (111)Indium-labelled microspheres in the liver (right and left hepatic artery, respectively), in both kidneys and in the gluteal musculature. In total, n = 18 transarterial injections were performed. RESULTS: In-vitro testing and in-vivo studies in mice documented high binding stability for both (99m)Technetium-labelled and (111)Indium-labelled microsphere fractions. In phantom studies, simultaneous dual-isotope SPECT/CT enabled reliable separation of both isotopes. In pigs, the identified deposition of both isotopes could be accurately matched with intended injection targets (100 %, 18/18 intended injection sites). Furthermore, an incidental deposition of (99m)Technetium-labelled microspheres in the stomach could be correlated to the test injection into a right hepatic artery. CONCLUSION: Simultaneous dual-isotope SPECT/CT after transarterial injection with (99m)Technetium- and (111)Indium-labelled microspheres is feasible. Thus, it may offer additional, valuable information compared to single (99m)Technetium-labelled albumin examinations. KEY POINTS: * Simultaneous dual-isotope SPECT/CT with (111) In- and (99m) Tc-labelled albumin microspheres is feasible. * Differentiation of two microsphere fractions after transarterial injection is possible. * The origin of an extra-hepatic microsphere deposition can be correlated to the corresponding artery. * This technique could reduce the setup time for selective internal radiation treatment.
Original languageEnglish
Pages (from-to)3062-3070
Number of pages9
JournalEuropean Radiology
Volume23
Issue number11
DOIs
Publication statusPublished - Nov 2013

Keywords

  • Liver
  • SIRT
  • Albumin microspheres
  • Simultaneous
  • Dual-isotope SPECT/CT
  • Y-90 MICROSPHERES
  • RADIOEMBOLIZATION
  • THERAPY
  • COMPLICATIONS
  • CANCER
  • CT

Cite this

Palmowski, M., Goedicke, A., Vogg, A., Christ, G., Muhlenbruch, G., Kaiser, H. J., Gunther, R. W., Kuhl, C. K., Mottaghy, F. M., & Behrendt, F. F. (2013). Simultaneous dual-isotope SPECT/CT with (99m)Tc- and (111)In-labelled albumin microspheres in treatment planning for SIRT. European Radiology, 23(11), 3062-3070. https://doi.org/10.1007/s00330-013-2916-9